Trials / Completed
CompletedNCT01332253
Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Trial of the Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 161 (actual)
- Sponsor
- Cumberland Pharmaceuticals · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis is that a single, pre-operative dose of intravenous ibuprofen will significantly reduce post-operative fentanyl use compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous ibuprofen | Participants will receive a single 10mg/kg dose of intravenous ibuprofen diluted in normal saline at the induction of anesthesia. |
| OTHER | Normal Saline | Participants will receive a comparable weight based volume of normal saline as a placebo comparator at the induction of anesthesia. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-07-01
- Completion
- 2012-08-01
- First posted
- 2011-04-11
- Last updated
- 2016-11-03
- Results posted
- 2016-11-03
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01332253. Inclusion in this directory is not an endorsement.